PMID- 35535905 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 1673-5374 (Print) IS - 1876-7958 (Electronic) IS - 1673-5374 (Linking) VI - 17 IP - 11 DP - 2022 Nov TI - Human umbilical cord-derived mesenchymal stem cells promote repair of neonatal brain injury caused by hypoxia/ischemia in rats. PG - 2518-2525 LID - 10.4103/1673-5374.339002 [doi] AB - Administration of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) is believed to be an effective method for treating neurodevelopmental disorders. In this study, we investigated the possibility of hUC-MSCs treatment of neonatal hypoxic/ischemic brain injury associated with maternal immune activation and the underlying mechanism. We established neonatal rat models of hypoxic/ischemic brain injury by exposing pregnant rats to lipopolysaccharide on day 16 or 17 of pregnancy. Rat offspring were intranasally administered hUC-MSCs on postnatal day 14. We found that polypyrimidine tract-binding protein-1 (PTBP-1) participated in the regulation of lipopolysaccharide-induced maternal immune activation, which led to neonatal hypoxic/ischemic brain injury. Intranasal delivery of hUC-MSCs inhibited PTBP-1 expression, alleviated neonatal brain injury-related inflammation, and regulated the number and function of glial fibrillary acidic protein-positive astrocytes, thereby promoting plastic regeneration of neurons and improving brain function. These findings suggest that hUC-MSCs can effectively promote the repair of neonatal hypoxic/ischemic brain injury related to maternal immune activation through inhibition of PTBP-1 expression and astrocyte activation. FAU - Jiao, Yang AU - Jiao Y AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University; Dalian Innovation Institute of Stem Cells and Precision Medicine; Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China. FAU - Sun, Yue-Tong AU - Sun YT AD - College of Life Science, Liaoning Normal University, Dalian, Liaoning Province, China. FAU - Chen, Nai-Fei AU - Chen NF AD - College of Life Science, Liaoning Normal University, Dalian, Liaoning Province, China. FAU - Zhou, Li-Na AU - Zhou LN AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center; Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China. FAU - Guan, Xin AU - Guan X AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University; Dalian Innovation Institute of Stem Cells and Precision Medicine, Dalian, Liaoning Province, China. FAU - Wang, Jia-Yi AU - Wang JY AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University; Dalian Innovation Institute of Stem Cells and Precision Medicine, Dalian, Liaoning Province, China. FAU - Wei, Wen-Juan AU - Wei WJ AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University; Dalian Innovation Institute of Stem Cells and Precision Medicine, Dalian, Liaoning Province, China. FAU - Han, Chao AU - Han C AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University; Dalian Innovation Institute of Stem Cells and Precision Medicine, Dalian, Liaoning Province, China. FAU - Jiang, Xiao-Lei AU - Jiang XL AD - College of Life Science, Liaoning Normal University, Dalian, Liaoning Province, China. FAU - Wang, Ya-Chen AU - Wang YC AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University; Dalian Innovation Institute of Stem Cells and Precision Medicine, Dalian, Liaoning Province, China. FAU - Zou, Wei AU - Zou W AD - Dalian Innovation Institute of Stem Cells and Precision Medicine; College of Life Science, Liaoning Normal University, Dalian, Liaoning Province, China. FAU - Liu, Jing AU - Liu J AD - Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine Center, The First Affiliated Hospital of Dalian Medical University; Dalian Innovation Institute of Stem Cells and Precision Medicine, Dalian, Liaoning Province, China. LA - eng PT - Journal Article PL - India TA - Neural Regen Res JT - Neural regeneration research JID - 101316351 PMC - PMC9120712 OTO - NOTNLM OT - developmental brain disease model OT - disease-associated astrocytes OT - intranasal administration OT - lipopolysaccharide OT - maternal immune activation OT - neonatal brain injury OT - neuroplasticity repair OT - polypyrimidine tract-binding protein-1 OT - stem cell therapy OT - umbilical cord-derived mesenchymal stem cells COIS- None EDAT- 2022/05/11 06:00 MHDA- 2022/05/11 06:01 PMCR- 2022/04/01 CRDT- 2022/05/10 07:58 PHST- 2022/05/10 07:58 [entrez] PHST- 2022/05/11 06:00 [pubmed] PHST- 2022/05/11 06:01 [medline] PHST- 2022/04/01 00:00 [pmc-release] AID - NeuralRegenRes_2022_17_11_2518_339002 [pii] AID - NRR-17-2518 [pii] AID - 10.4103/1673-5374.339002 [doi] PST - ppublish SO - Neural Regen Res. 2022 Nov;17(11):2518-2525. doi: 10.4103/1673-5374.339002.